生物标志物 生物标志物
Muhammad Ali1,2, Ying Xu1,2, Gyujin Heo1
1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
这项研究确定了脑脊液和血中独特的蛋白质签名,以区分神经退行性疾病 (NDs),如阿尔茨海默氏症和帕金森病,有助于向治疗.
科学领域:
- 神经保护学是神经保护学.
- 生物标志物发现发现
- 神经退行性疾病 神经退行性疾病
背景情况:
- 神经退行性疾病 (NDs),如阿尔茨海默病 (AD),帕金森病 (PD),前性痴呆症 (FTD) 和患有莱维体 (DLB) 的痴呆症,具有重叠的临床特征,使诊断复杂化.
- 准确的区分对于有效的治疗和了解疾病机制至关重要.
- 蛋白质组学提供了一种强大的工具,用于识别特定疾病的分子特征和生物标志物.
研究的目的:
- 在脑脊液 (CSF) 和血中识别疾病特异性蛋白质特征,以区分NDs.
- 开发针对AD,PD,FTD和DLB的准确诊断和分类模型.
- 阐明不同的NDs背后的共同和独特的分子途径.
主要方法:
- 在AD,PD,FTD,DLB和对照组中,SomaScan对2,705个脊髓和3,009个血样本进行蛋白质分析.
- 鉴定和验证与疾病相关的蛋白质 (FDR < 0.05).
- 开发预测模型和路径丰富分析.
主要成果:
- 在CSF和血中都发现了疾病特异性蛋白质,CSF显示了更多的相关蛋白质.
- 脑脊髓在DLB和FTD之间 (r2=0.89),以及在AD和DLB之间 (r2=0.59/0.77) 显示出更强的组织特异性相似性.
- 在CSF (AUC 0.81-0.95) 和血 (AUC 0.8-0.89) 中,针对AD,PD,FTD和DLB开发了准确的预测模型.
- 路径分析揭示了常见的神经炎症路径和每个疾病的独特路径,包括AD中的突触损伤,PD中的ER压力,DLB中的微质激活和FTD中的干扰素信号传递.
结论:
- 跨ND的共享和独特的分子途径被划分出来,突出了由不同的分子因素驱动的常见神经退行过程.
- 发现了独特的分子特征和融合途径,如神经炎症和突触可塑性.
- 这些发现支持有针对性的治疗策略,并推进神经退行症的精准医学.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516